← Eichor
Condition: Mastocytosis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Mastocytosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)
Phase N/A · 1 location(s) · Blueprint Medicines Corporation · NCT07264959Epidemiological Data on Mast Cell Pathologies in France
Phase N/A · 21 location(s) · Imagine Institute · NCT06186856Study of Factors Regulating Mast Cell Proliferation
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00044122Avapritinib With Decitabine in Patients With SM-AHN
Phase 1 · 7 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT06327685Analysis of the Role of IgE Proteoforms in Health and Disease
Phase N/A · 1 location(s) · KU Leuven · NCT07328178Mastocytosis Registry (of Zurich)
Phase N/A · 1 location(s) · University of Zurich · NCT06466889Avapritinib Rollover Study
Phase 4 · 7 location(s) · Blueprint Medicines Corporation · NCT06748001Registry of Older Patients With Cancer
Phase N/A · 7 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137825Peripheral Blood KIT-D816V Mutation in Adult Systemic Mastocytosis
Phase N/A · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT075625423'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Phase N/A · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT00935090A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany
Phase N/A · 8 location(s) · Blueprint Medicines Corporation · NCT07255638Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers
Phase 2 · 10 location(s) · Fred Hutchinson Cancer Center · NCT03779854Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Phase N/A · 19 location(s) · Blueprint Medicines Corporation · NCT07143669Mastocytosis From Pediatric Age to Adulthood: Local Registry of Cutaneous and Systemic Mastocytosis
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07142473(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Phase 2/Phase 3 · 71 location(s) · Blueprint Medicines Corporation · NCT04910685(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Phase 2 · 42 location(s) · Cogent Biosciences, Inc. · NCT04996875Relationship Between Circulating Sclerostin and Bone Lesions in Patients With Mastocytosis
Phase N/A · 1 location(s) · Medical University of Lublin · NCT06440148Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Phase N/A · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137643Institutional Registry of Rare Diseases
Phase N/A · 1 location(s) · Hospital Italiano de Buenos Aires · NCT06573723Myeloproliferative Neoplasms (MPNs) Patient Registry
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT02760238
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.